OTCMKTS:KDSKF DSM-Firmenich (KDSKF) Stock Price, News & Analysis $25.30 0.00 (0.00%) As of 10/17/2024 Add Compare Share Share Stock Analysis Stock AnalysisHeadlinesBuy This Stock About DSM-Firmenich Stock (OTCMKTS:KDSKF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DSM-Firmenich alerts:Sign Up Key Stats Today's Range$25.30▼$25.3050-Day Range$25.30▼$25.3052-Week Range$12.50▼$120.00VolumeN/AAverage Volume303 shsMarket CapitalizationN/AP/E Ratio26.69Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewDSM the Life Sciences and Materials Sciences Company Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSMs products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam.Read More… Receive KDSKF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DSM-Firmenich and its competitors with MarketBeat's FREE daily newsletter. Email Address KDSKF Stock News HeadlinesDSM-Firmenich AG (KDSKF) Q1 2025 Earnings Call TranscriptMay 2 at 4:19 PM | seekingalpha.comdsm-firmenich completes shareholding increase in Andre Pectin to 90.5%April 5, 2025 | finance.yahoo.comBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.May 3, 2025 | Crypto 101 Media (Ad)PE Firms Said to Study DSM-Firmenich’s €3 Billion UnitApril 3, 2025 | bloomberg.comPeijia Medical partners with dsm-firmenich on polymer heart valve materialsApril 2, 2025 | msn.comDSM-Firmenich AG (DSFIR): New Buy Recommendation for This Basic Materials GiantMarch 27, 2025 | markets.businessinsider.comEXCLUSIVE: Initio Parfums Privés Teams With Dsm-Firmenich on Functional FragrancesFebruary 26, 2025 | msn.comKepler Capital Sticks to Their Buy Rating for DSM-Firmenich AG (DSFIR)February 20, 2025 | markets.businessinsider.comSee More Headlines KDSKF Stock Analysis - Frequently Asked Questions How have KDSKF shares performed this year? DSM-Firmenich's stock was trading at $25.30 at the beginning of 2025. Since then, KDSKF stock has increased by 0.0% and is now trading at $25.30. View the best growth stocks for 2025 here. How do I buy shares of DSM-Firmenich? Shares of KDSKF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorBasic Materials Industry Specialty Chemicals Sub-IndustryN/A Current SymbolOTCMKTS:KDSKF CIK1339422 Webwww.dsm.com Phone(145) 578-8111FaxN/AEmployees19,263Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio26.69 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (OTCMKTS:KDSKF) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DSM-Firmenich AG Please log in to your account or sign up in order to add this asset to your watchlist. Share DSM-Firmenich With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.